Ensitrelvir (S-217622) Intermedia CAS 1360105-53-8 Puritas >98.0% COVID-19
Commercial Supple Ensitrelvir (S-217622) Intermedia:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl) -1-methyl-1H-1,2,4-triazolum hydrochloridum CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8
| Nomen chemicum | 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- |
| Synonyma | 3-tert-butyl-6-(ethylthio)-1,3,5-triazino-2,4(1H,3H)-dione |
| CAS Number | 1360105-53-8 |
| CATTUS Number | RF-PI1504 |
| Stock Status | In Stock |
| Formulae hypotheticae | C9H15N3O2S |
| M. Pondus | 229.3 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Puritas | >98.0% |
| Damnum in Siccatio | <1.00% |
| Totalis immunditias | <2.00% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Medium Ensitrelvir (S-217622), COVID-19 . |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
3-(Chloromethyl) -1-methyl-1H-1,2,4-triazolum hydrochloridum (CAS: 135206-76-7) est medium Ensitrelviri (S-217622).Ensitrelvir medicamentum antivirale a Shionogi in societate cum Hokkaido University evolvitur, quod ore activo 3C-similis protease inhibitor agit ad infectionem curationis COVID-19.Ore capitur, et feliciter probatum est contra variantes Omicron nuper prodiit.Factus est primum pilum domesticum Iapones tractare COVID-19, tertium in Iaponia regulariter approbari;mense Februario MMXXII.
-
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3 P...
-
3-(Chloromethyl) -1-methyl-1H-1,2,4-triazolum hyd...
-
6-Chloro-2-methyl-2H-indazol-5-amine CAS 189312...
-
Ensitrelvir (S-217622) Intermedia CAS 1360105...
-
S-Ethylisothiourea Hydrobromide CAS 1071-37-0 P...
-
Trimethyloxonium Tetrafluoroborate CAS 420-37-1...